Miguel Regueiro - Department of Gastroenterology, Digestive Disease and Surgery Institute, Cleveland Clinic

基本信息

浏览量：146

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 809 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Potential Predictors of Efficacy Outcomes Following Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission: a Post Hoc Analysis of Outcomes from the RIVETING Study

Joana Torres, Geert R D'Haens,Miguel Regueiro, Genoile Santana,Julian Panés,Séverine Vermeire,Sean Gardiner,Nicole Kulisek,Irene Modesto,Chinyu Su,Nervin Lawendy,Rajiv Mundayat,Jerome Paulissen,Marla C Dubinsky

Therapeutic advances in gastroenterology (2025): 17562848251318849-17562848251318849

引用0浏览0WOS引用

Racial Disparities in Utilization of Medications and Disease Outcomes in Inflammatory Bowel Disease Patients

Khaled Alsabbagh Alchirazi, Osama Hamid, Thabet Qapaja,Mohammad Aldiabat, Nour Azzouz,Motasem Alkhayyat,Miguel Regueiro

Crohn's & colitis 360no. 2 (2025): otaf021-otaf021

引用0浏览0WOS引用

DOP005 Long-term Efficacy and Safety of Mirikizumab Treatment for Crohn’s Disease: Results from the VIVID-2 Open-Label Extension Study

S Vermeire,B E Sands,G D’Haens,T Hisamatsu, C R Kelly, N Lu,N Morris, R Moses, F Durand,M Protic, R, M U Lopes,M Regueiro,D Laharie

Journal of Crohn's and Colitisno. Supplement_1 (2025)

引用0浏览0引用

Trajectories of Response in Patients with Moderately-to-severely Active Ulcerative Colitis Treated with Mirikizumab: Results from the LUCENT-1 Study

S. W. Schreiber, D. B. Clemow, A. Keohane,B. Zhu, T. Ritter,M. Regueiro,D. Hudesman, Y. F. Chen, C. Owen

JOURNAL OF CROHNS & COLITIS (2025): I1975-I1976

引用0浏览0引用

Cardiovascular Events Observed among Patients in the Etrasimod Clinical Programme: an Integrated Safety Analysis of Patients with Moderately to Severely Active Ulcerative Colitis

Séverine Vermeire,David T Rubin,Laurent Peyrin-Biroulet,Marla C Dubinsky,Miguel Regueiro,Peter M Irving,Martina Goetsch,Krisztina Lazin,Guibao Gu,Joseph Wu,Irene Modesto,Aoibhinn McDonnell, Xiang Guo,Jesse Green, Alexis B Dalam,Andres J Yarur

BMJ open gastroenterologyno. 1 (2025)

引用0浏览0WOS引用

P0702 Efficacy of Subcutaneous Infliximab Maintenance Therapy According to Disease Location in Patients with Moderate-to-severe Crohn’s Disease: A Post Hoc Analysis of the Phase 3 LIBERTY-CD Study

S. W. Schreiber,J. F. Colombel,M. C. Dubinsky,B. E. Sands, B. P. Abraham,M. Regueiro,S. Danese, H. Park, D. H. Kim, Y. N. Lee,S. B. Hanauer

JOURNAL OF CROHNS & COLITIS (2025): I1372-I1373

引用0浏览0引用

Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial

Bruce E Sands,David T Rubin,Edward V Loftus,Douglas C Wolf,Remo Panaccione,Jean-Frederic Colombel,Axel Dignass,Miguel Regueiro,Severine Vermeire,Anita Afzali,Garrett Lawlor,Harris A Ahmad,Hsiuanlin Wu,Mark T Osterman,Anjali Jain,Geert D'Haens

The American journal of gastroenterology（2025）

引用0浏览0WOS引用

Long-term Efficacy and Safety of Mirikizumab Treatment for Crohn's Disease: Results from the VIVID-2 Open-Label Extension Study

S. Vermeire,B. E. Sands,G. D'Haens,T. Hisamatsu, C. R. Kelly, N. Lu,N. Morris, R. Moses, F. Durand,M. Protic,R. R. Hozak, M. U. Lopes,M. Regueiro,D. Laharie

JOURNAL OF CROHNS & COLITIS (2025): i87-i89

引用0浏览0引用

A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice

Jessica K Salwen-Deremer,Sarah Ballou, Megan Petrik,Miguel Regueiro,Corey A Siegel,Laurie Keefer, GastroPsych Business Plan Working Group

Gastroenterology (2025)

引用0浏览0WOS引用

The Use of Exhaled Volatile Organic Compounds for the Non-Invasive Assessment of Endoscopic Inflammation in Patients with Ileal Pouch Anal Anastomosis (IPAA)

T. Qazi,B. Cohen, J. Ma, Q. Yang,D. Grove,M. Regueiro,R. Dweik,F. Rieder

JOURNAL OF CROHNS & COLITIS (2025): i848-i848

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn